Literature DB >> 16584142

Spray-dried mucoadhesive microspheres: preparation and transport through nasal cell monolayer.

Saraporn Harikarnpakdee1, Vimolmas Lipipun, Narueporn Sutanthavibul, Garnpimol C Ritthidej.   

Abstract

The purpose of this research was to prepare spray-dried mucoadhesive microspheres for nasal delivery. Microspheres composed of hydroxypropyl methylcellulose (H), chitosan (CS), carbopol 934P (CP) and various combinations of these mucoadhesive polymers, and maltodextrin (M), colloidal silicon dioxide (A), and propylene glycol (P) as filler and shaper, were prepared by spray-drying technique. Using propranolol HCl as a model drug, microspheres were prepared at loadings exceeding 80% and yields between 24% and 74%. Bulky, free flowing microspheres that had median particle size between 15 and 23 mum were obtained. Their zeta potential was according to the charge of polymer. Adhesion time of mucoadhesive microspheres on isolated pig intestine was ranked, CS > CP:H > CP > H, while the rank order of swelling was CP > CS > H. Increasing the amount of CP in CP:H formulations increased the percentage of swelling. Infrared (IR) spectra showed no interaction between excipients used except CS with acetic acid. The release of drug from CP and CP:H microspheres was slower than the release from H and CS microspheres, correlated to their viscosity and swelling. Long lag time from the CP microspheres could be shortened when combined with H. The permeation of drug through nasal cell monolayer corresponded to their release profiles. These microspheres affected the integrity of tight junctions, relative to their swelling and charge of polymer. Cell viability was not affected except from CS microspheres, but recovery could be obtained. In conclusion, spray-dried microspheres of H, CS, CP, and CP:H could be prepared to deliver drug through nasal cell monolayer via the opening of tight junction without cell damaging.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16584142      PMCID: PMC2750719          DOI: 10.1208/pt070112

Source DB:  PubMed          Journal:  AAPS PharmSciTech        ISSN: 1530-9932            Impact factor:   3.246


  23 in total

1.  Moist heat treatment on physicochemical change of chitosan salt films.

Authors:  Garnpimol C Ritthidej; Thawatchai Phaechamud; Tamotsu Koizumi
Journal:  Int J Pharm       Date:  2002-01-31       Impact factor: 5.875

Review 2.  The nose and paranasal sinuses physiology and anatomy.

Authors:  N Jones
Journal:  Adv Drug Deliv Rev       Date:  2001-09-23       Impact factor: 15.470

3.  Transport of chitosan microparticles for mucosal vaccine delivery in a human intestinal M-cell model.

Authors:  I M van der Lubben; F A C van Opdorp; M R Hengeveld; J J M Onderwater; H K Koerten; J C Verhoef; G Borchard; H E Junginger
Journal:  J Drug Target       Date:  2002-09       Impact factor: 5.121

4.  Preparation and evaluation of the in vitro drug release properties and mucoadhesion of novel microspheres of hyaluronic acid and chitosan.

Authors:  S T Lim; G P Martin; D J Berry; M B Brown
Journal:  J Control Release       Date:  2000-05-15       Impact factor: 9.776

5.  Effect of chitosan on the permeability of monolayers of intestinal epithelial cells (Caco-2).

Authors:  P Artursson; T Lindmark; S S Davis; L Illum
Journal:  Pharm Res       Date:  1994-09       Impact factor: 4.200

6.  Characterization of human nasal primary culture systems to investigate peptide metabolism.

Authors:  Vu Dang Hoang; Agu Remigius Uchenna; Jorissen Mark; Kinget Renaat; Verbeke Norbert
Journal:  Int J Pharm       Date:  2002-05-15       Impact factor: 5.875

7.  Effects of polyether-modified poly(acrylic acid) microgels on doxorubicin transport in human intestinal epithelial Caco-2 cell layers.

Authors:  Lev Bromberg; Valery Alakhov
Journal:  J Control Release       Date:  2003-02-14       Impact factor: 9.776

8.  Controlled release of interleukin-2 from chitosan microspheres.

Authors:  Suna Ozbaş-Turan; Julide Akbuğa; Cenk Aral
Journal:  J Pharm Sci       Date:  2002-05       Impact factor: 3.534

9.  Formulation factors in preparing BTM-chitosan microspheres by spray drying method.

Authors:  Y Huang; M Yeh; C Chiang
Journal:  Int J Pharm       Date:  2002-08-21       Impact factor: 5.875

10.  Caffeine microparticles for nasal administration obtained by spray drying.

Authors:  C Sacchetti; M Artusi; P Santi; P Colombo
Journal:  Int J Pharm       Date:  2002-08-21       Impact factor: 5.875

View more
  6 in total

Review 1.  Pharmaceutical particle engineering via spray drying.

Authors:  Reinhard Vehring
Journal:  Pharm Res       Date:  2007-11-28       Impact factor: 4.200

2.  Mucoadhesive microspheres for gastroretentive delivery of acyclovir: in vitro and in vivo evaluation.

Authors:  Sumeet Dhaliwal; Subheet Jain; Hardevinder P Singh; A K Tiwary
Journal:  AAPS J       Date:  2008-06-04       Impact factor: 4.009

3.  Effects of spray drying on physicochemical properties of chitosan acid salts.

Authors:  Mirna Fernández Cervera; Jyrki Heinämäki; Nilia de la Paz; Orestes López; Sirkka Liisa Maunu; Tommi Virtanen; Timo Hatanpää; Osmo Antikainen; Antonio Nogueira; Jorge Fundora; Jouko Yliruusi
Journal:  AAPS PharmSciTech       Date:  2011-05-11       Impact factor: 3.246

4.  Formulation and characterization of nanoemulsion intranasal adjuvants: effects of surfactant composition on mucoadhesion and immunogenicity.

Authors:  Pamela T Wong; Su He Wang; Susan Ciotti; Paul E Makidon; Douglas M Smith; Yongyi Fan; Charles F Schuler; James R Baker
Journal:  Mol Pharm       Date:  2013-12-13       Impact factor: 4.939

5.  Agglomerates containing pantoprazole microparticles: modulating the drug release.

Authors:  Renata P Raffin; Paolo Colombo; Fabio Sonvico; Alessandra Rossi; Denise S Jornada; Adriana R Pohlmann; Silvia S Guterres
Journal:  AAPS PharmSciTech       Date:  2009-03-25       Impact factor: 3.246

6.  Development of in vitro models to demonstrate the ability of PecSys®, an in situ nasal gelling technology, to reduce nasal run-off and drip.

Authors:  Jonathan Castile; Yu-Hui Cheng; Ben Simmons; Michael Perelman; Alan Smith; Peter Watts
Journal:  Drug Dev Ind Pharm       Date:  2012-07-17       Impact factor: 3.225

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.